Gamma-aminobutyric acid type A receptor subunit alpha 3 (GABRA3) (GABRA3)

The Gamma-aminobutyric acid type A (GABA_A) receptor subunit alpha 3 (GABRA3) is a critical component of pentameric ligand-gated chloride channels that mediate fast inhibitory neurotransmission in the central nervous system (UniProt: P34903). These receptors typically consist of two alpha, two beta, and one gamma subunit; the α3-containing variants are prominently expressed in the amygdala, thalamus, and the dorsal horn of the spinal cord, distinguishing them from the more ubiquitous α1-containing receptors (PubMed: 22403129). Biologically, α3-containing GABA_A receptors are integral to the modulation of emotional states, muscle tone, and the processing of sensory information, including nociception. In clinical contexts, dysfunction or reduced expression of the α3 subunit is implicated in the pathophysiology of anxiety disorders, chronic neuropathic pain, and cognitive impairments associated with schizophrenia (PubMed: 30107231). While traditional benzodiazepines act as non-selective positive allosteric modulators (PAMs) across multiple alpha subunits, modern drug discovery focuses on α3-selective or α2/α3-preferring PAMs to achieve anxiolytic and analgesic effects while minimizing the sedation and amnesia typically linked to α1 activation (PubMed: 28830757). The designation α3βX specifically highlights the heteromeric assembly of the alpha 3 subunit with various beta subunit isoforms (β1-3) to form functional receptor complexes.

Other names

GABA(A) receptor subunit alpha-3GABA-A receptor alpha-3 subunitGABRA3GABA_A receptor alpha 3Alpha-3 subunit of GABA-A receptor

Positive allosteric modulation of the GABA-induced chloride current